A version of this story first appeared in STAT Health Tech, our weekly newsletter about how tech is transforming health care and the life sciences. Sign up here to receive it in your inbox.
For many ambitious health-tech startups, the holy grail is clear: landing a deal with a large biopharma company.
That makes Patrick Dey a sought-after man. He’s a vice president at Amgen who heads up digital health and innovation. And he and his team spend lots of their time thinking about how to find the best health-tech startups to partner with.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect